null - FindTrial

N/A - BEST-MS

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2013-002433-38-FR

Enrollment

100

Registered

2015-09-25

Start date

2013-09-12

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: TYSABRI Product Name: natalizumab Pharmaceutical Form: Concentrate for solution for infusion Trade Name: GILENYA Product Na

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 600 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Main Objective: ;Secondary Objective: ;Primary end point(s):	—

Countries

France

Contacts

Public ContactARC promoteur

CHU Toulouse

vernet.d@chu-toulouse.fr3305 6177 72 16

Outcome results